Skip to content
Invitrocue - Transforming bioanalytics
  • Home
  • About Us
    • Meet Invitrocue
    • Our Team
    • Partners
    • Corporate Governance
    • Careers
  • Oncology
    • Onco-PDO™
    • Patient FAQ
    • Physician FAQ
  • Preclinical Services
    • Overview
    • Drug Metabolism and Pharmacokinetics
    • Toxicology and Safety Assessment
    • Hepatocytes
    • 3D Cell Culture
    • Customized Assays and Disease Modelling
    • Invivocue’s HiMice
  • Shareholders
    • Reports
      • Financial Reports
      • Analyst Reports
    • Announcements
    • Contact Management
  • News & Resources
    • Publications
    • Conferences & Events
    • Press Releases
    • Privacy Policy
  • Contact Us
  • English
    • English
    • Deutsch
    • Español
    • Português
    • 中文 (中国)
    • 中文 (香港)
Menu
  • Home
  • About Us
    • Meet Invitrocue
    • Our Team
    • Partners
    • Corporate Governance
    • Careers
  • Oncology
    • Onco-PDO™
    • Patient FAQ
    • Physician FAQ
  • Preclinical Services
    • Overview
    • Drug Metabolism and Pharmacokinetics
    • Toxicology and Safety Assessment
    • Hepatocytes
    • 3D Cell Culture
    • Customized Assays and Disease Modelling
    • Invivocue’s HiMice
  • Shareholders
    • Reports
      • Financial Reports
      • Analyst Reports
    • Announcements
    • Contact Management
  • News & Resources
    • Publications
    • Conferences & Events
    • Press Releases
    • Privacy Policy
  • Contact Us
  • English
    • English
    • Deutsch
    • Español
    • Português
    • 中文 (中国)
    • 中文 (香港)

Analyst
Reports

Investors

Financial
Reports

Analyst
Reports

Press
Releases

ASX
Announcements

Investors

Financial Reports

Analyst Reports

Announcements

Shareholders

Biotech Daily May 2019 – Dr Boreham's Crucible

READ MORE >
June 13, 2019

Gordon Capital – October 2019 Research Updates

READ MORE >
February 13, 2019

NDF Research – 2019: Another year of progress expected for Onco-PDO

READ MORE >
February 7, 2019

Wise-Owl – December 2018 Updates

READ MORE >
December 19, 2018

Gordon Capital – October 2018 Research Updates

READ MORE >
November 9, 2018

Gordon Capital – October 2018 Research Updates

READ MORE >
October 27, 2018

Wise-Owl – Initiation of Coverage

READ MORE >
August 27, 2018

Gordon Capital – June Quarter 2018 Cash Flow Report

READ MORE >
August 24, 2018

NDF Research – Initiation of Coverage

READ MORE >
April 20, 2018

GET IN TOUCH

51 Science Park Road, #01-11/13
The Aries, Singapore Science Park II
Singapore 117586

+65 6460 0497

contact@invitrocue.com

SERVICES

Home
About Us
Oncology
Preclinical Services
Investors
News & Resources
Contact Us

Logo Invitrocue
Twitter Facebook-f Linkedin-in Youtube

© Copyright 2022 Invitrocue. All rights reserved
Impressum | Privacy Policy | Cookies Policy | Cookie Settings